Status:
RECRUITING
Glioblastoma Radiotherapy Using IMRT or Proton Beams
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Glioblastoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Radiation therapy is an integral part of the multimodal primary therapy of glioblastomas. As the overall prognosis in this tumor entity remains unfavorable, current research is focused on additional d...
Eligibility Criteria
Inclusion
- histologically confirmed gliomblastoma WHO IV (operated or after biopsy)
- Indication for radiotherapy / radiochemotherapy
- Informed consent
- KI ≥ 60% or ECOG 0/1
- Age ≥ 18 years
- Sufficient effective contraception
Exclusion
- Patient is not able to consent
- Previous radiotherapy in the brain or skull base
- Active medical implants for which there is no ion radiation authorization at the time of treatment (e.g., cardiac pacemaker, defibrillator, ...)
- Contraindication to MRI imaging
- Simultaneous participation in another clinical trial that could influence the outcome of this study or other study
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 19 2027
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT04752280
Start Date
April 19 2021
End Date
October 19 2027
Last Update
January 5 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Heidelberg
Heidelberg, Germany
2
Universitätsklinikum Gießen und Marburg
Marburg, Germany
3
Klinikum Stuttgart
Stuttgart, Germany